Considering the shared underlying mechanisms across PAD, CAD, and CVD, including endothelial dysfunction, dysregulated metabolism, and systemic atherosclerosis [4], examining the role of GDF15 in predicting systemic cardiovascular risk, specifically in the PAD population, represents a critical and underdeveloped area of research. Here, GDF15 is linked to endothelial dysfunction.